Bayer Intellectual Property Gmbh

Bayer Aktiengesellschaft

Bayer Pharma Aktiengesellschaft

Hubert Trübel

Martina Delbeck

Carsten Schmeck

Peter Kolkhof

Axel Kretschmer

Elisabeth Pook

Chantal Fürstner

Joerg Keldenich

Jörg Keldenich

Ulf Brüggemeier

Armin Kern

Ingo Pluschkell

Heinrich Meier

Stefan Golz

Volker Geiss

Andreas Geerts

Martin Van Eickels

Volker Geiβ

Carlos Castellon

Frank Kramer

Wilfried Dinh

Thomas Mondritzki

Philip Patrick Böhme

Chantal Furstner

Chantal FÜRSTNER

The invention relates to the technical field of supporting patients in the repeated taking of drugs within the context of a therapeutic treatment. The invention relates to a method, to a system, and to a computer program product that monitor the taking of drugs by a patient and inform the patient or a doctor or another person if a drug portion should not be taken in order to thus optimize the effectiveness of the treatment or reduce risks.

Supporting patients in the repeated taking of drugs

The present invention relates to the use of cathepsin K and/or cathepsin S inhibitors in a method for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure.

Use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure

The present application relates to novel bisaryl-linked 5-aryl-1,2,4-triazolone derivatives, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.

Bisaryl-bonded aryltriazolones and use thereof

The present invention relates to bisaryl-linked 5-aryl-1,2,4-triazolone derivatives according to the following formula: 

The present application relates to novel substituted N-phenethyltriazoloneacetamides, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.

[object Object]

The present application relates to novel substituted phenylacetamides and phenylpropanamides, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.

Substituted phenylacetate and phenylpropane amides and use thereof

The present application relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.

Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof

Growing community of inventors

Wuppertal, Germany

Hubert Trübel